Laboratory Proficiency Testing Market: Market Size & Forecast 2026

Proficiency testing involves organized external quality assessment programs in which laboratories regularly test unknown samples and compare their results against established target values to evaluate performance. This process is foundational to clinical laboratory accreditation and is mandated by regulatory frameworks including CLIA in the United States, UKAS in the United Kingdom, and ISO 15189 internationally. The market spans clinical diagnostics, pharmaceutical quality control, food and beverage safety testing, environmental monitoring, and research applications. Rising global testing volumes and tightening regulatory expectations have made PT an essential, recurring expense for laboratories across all sectors.

• •External quality assessment for laboratory accuracy
• •Mandated under CLIA, CAP, and ISO standards
• •Spans clinical, pharmaceutical, and environmental labs

Regulatory compliance is the primary catalyst for market expansion, as accreditation bodies increasingly require or strongly encourage participation in accredited PT programs as a condition of laboratory operation. The rising prevalence of chronic and infectious diseases drives higher diagnostic testing volumes, which in turn increases the frequency and scope of PT participation across clinical laboratories. Technological advances in molecular diagnostics, next-generation sequencing, and point-of-care testing create demand for new, specialized PT schemes that cover emerging assay types and biomarkers.

• •Regulatory mandates for lab accreditation worldwide
• •Growing diagnostic testing volumes from aging populations
• •Emerging technologies requiring new PT schemes

The market is organized by provider type, including independent EQA program operators, in-house PT offerings from diagnostics manufacturers, and centralized government-sponsored programs. By end user, clinical and hospital laboratories represent the largest segment, followed by pharmaceutical and biotechnology quality control, with food safety and environmental testing as smaller but growing segments. Geographically, North America leads due to the stringent CLIA and CAP requirements, Europe follows with mature EQA infrastructure, and Asia-Pacific is the fastest-growing region driven by healthcare modernization in China, India, and Southeast Asia.

• •Clinical and hospital labs dominate end-user demand
• •North America leads, Asia-Pacific grows fastest
• •Regulatory divergence creates regional program differences

What are the recent trends and outlook?

Digital platforms are streamlining PT workflows through automated sample tracking, electronic result submission, and real-time performance dashboards that reduce administrative burden for laboratories. Personalized medicine and companion diagnostics are creating demand for PT programs specialized to rare biomarkers and targeted therapies. Over the forecast horizon, the market is expected to benefit from continued expansion of accredited laboratory networks in emerging economies and sustained investment in quality assurance infrastructure globally.

• •Digital PT platforms improve laboratory efficiency
• •Personalized medicine drives specialized PT demand
• •Emerging economies expanding lab accreditation